|
Satellite
Symposium
The
history
of
RANKL
discovery
Supported
by
Amgen
/
GlaxoSmithKline
Webcast (Windows streaming media)
Sponsored by Amgen in collaboration with GSK
|
The
early
days
David
Lacey
(San
Francisco,
USA)
|
|
Effects
of
denosumab
on
bone
turnover,
microarchitecture
and
strength
in
non-human
primates
Mary
Bouxsein
(Boston,
USA)
|
|
Denosumab
in
the
clinic:
from
surrogate
endpoint
to
fracture
reduction
Christian
Roux
(Paris,
France)
|
|
